Beijing Scitop Bio-tech Co., Ltd. (300858.SZ)
CNY 15.82
(0.76%)
CNY 15.82
(0.76%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 123.92 Million CNY | -41.17% |
| 2022 | 144.75 Million CNY | 12.73% |
| 2021 | 128.34 Million CNY | 4.72% |
| 2020 | 124.26 Million CNY | 6.45% |
| 2019 | 116.79 Million CNY | 2.75% |
| 2018 | 109.12 Million CNY | 20.64% |
| 2017 | 91.83 Million CNY | 329.41% |
| 2016 | 24.74 Million CNY | -56.27% |
| 2015 | 49.45 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 24.23 Million CNY | 18.65% |
| 2024 Q3 | 29.34 Million CNY | -11.35% |
| 2024 Q1 | 20.94 Million CNY | -5.22% |
| 2023 Q3 | 35.64 Million CNY | 67.53% |
| 2023 FY | - CNY | -41.17% |
| 2023 Q4 | 21.11 Million CNY | -40.77% |
| 2023 Q1 | 23.66 Million CNY | -18.1% |
| 2023 Q2 | 21.27 Million CNY | -10.1% |
| 2022 Q2 | 25.49 Million CNY | -0.32% |
| 2022 Q4 | 28.89 Million CNY | -38.07% |
| 2022 Q3 | 46.66 Million CNY | 83.02% |
| 2022 Q1 | 25.57 Million CNY | -33.71% |
| 2022 FY | - CNY | 12.73% |
| 2021 FY | - CNY | 4.72% |
| 2021 Q4 | 38.58 Million CNY | 66.68% |
| 2021 Q2 | 29.42 Million CNY | 39.78% |
| 2021 Q3 | 23.14 Million CNY | -21.33% |
| 2021 Q1 | 21.05 Million CNY | -4.23% |
| 2020 Q2 | 28.25 Million CNY | 33.19% |
| 2020 FY | - CNY | 6.45% |
| 2020 Q3 | 40.44 Million CNY | 43.13% |
| 2020 Q1 | 21.21 Million CNY | -24.89% |
| 2020 Q4 | 21.98 Million CNY | -45.65% |
| 2019 Q2 | 33.44 Million CNY | 103.25% |
| 2019 FY | - CNY | 2.75% |
| 2019 Q4 | 28.24 Million CNY | -11.17% |
| 2019 Q3 | 31.8 Million CNY | -4.91% |
| 2019 Q1 | 16.45 Million CNY | 0.0% |
| 2018 Q1 | 24.83 Million CNY | 0.0% |
| 2018 Q2 | 24.83 Million CNY | 0.0% |
| 2018 FY | - CNY | 20.64% |
| 2017 FY | - CNY | 329.41% |
| 2016 FY | - CNY | -56.27% |
| 2015 FY | - CNY | 0.0% |